|
MRI Study of Brain Activity and Risk for Depression in Adolescents Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about MRI Study of Brain Activity and Risk for Depression in Adolescents conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. MRI Study of Brain Activity and Risk for Depression in Adolescents Clinical research trials and MRI Study of Brain Activity and Risk for Depression in Adolescents healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as MRI Study of Brain Activity and Risk for Depression in Adolescents. MRI Study of Brain Activity and Risk for Depression in Adolescents Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a MRI Study of Brain Activity and Risk for Depression in Adolescents clinical trial. Subjects frequently obtain the most expert healthcare possible for their MRI Study of Brain Activity and Risk for Depression in Adolescents condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > MRI Study of Brain Activity and Risk for Depression in Adolescents  MRI Study of Brain Activity and Risk for Depression in Adolescents
MRI Study of Brain Activity and Risk for Depression in Adolescents
For Condition: Anxiety Disorders,Involutional Depression
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: This study will use magnetic resonance imaging (MRI) to investigate brain changes in adolescents at risk for Major Depressive Disorder. It also calls for healthy volunteers to compare to children at risk for major depression. Children whose parents have major depressive disorder (MDD) are at risk for developing MDD. Children who experience anxiety are particularly at risk. This study will examine whether the risk for MDD is associated with changes in brain regions involved in the regulation of emotion and with anxiety early in life. Adolescents who have a parent with MDD and a history of anxiety symptoms will be compared to healthy volunteer adolescents who have no family history of MDD or childhood anxiety. Participants and their parents will have three outpatient study visits to NIH. Visit 1 will include a medical history, physical examination, questionnaires on thoughts and feelings, and tests to measure intelligence. During Visit 2, participants will perform memory and problem-solving tests and taught how to do tasks similar to those they will perform during Visit 3. The tasks involve looking at pictures, remembering things, and making decisions. During some of these tasks, the participant's eye movements will be tracked using a safe infrared light. At Visit 3, participants perform the tasks introduced on Visit 2 while in the MRI.
Details: Anxiety in children of parents with major depressive disorder (MDD) poses a particularly high risk for later-life MDD. In adults, MDD involves dysfunction in prefrontal brain regions that regulate attention to emotional stimuli. These abnormalities: i) have been found primarily in adults with specific familial forms of MDD; ii) persist after recovery from MDD, and iii) relate to anxiety. These findings raise the possibility that risk for MDD is tied to dysfunction in prefrontal regions involved in regulation of emotion, which possibly manifests as early-life anxiety. If this possibility were confirmed in never-depressed adolescents at high risk for MDD, the findings would provide key insights into the developmental neurobiology of MDD. The goal of this protocol is to study the neural substrate of risk for MDD in young people. This protocol tests the hypothesis that adolescents at high risk for MDD by virtue of childhood anxiety and parental history of MDD exhibit dysfunction in prefrontal cortex and amygdala, regions involved in emotion regulation. This goal will be accomplished through fMRI studies of emotion regulation in high and low-risk adolescents. For this research, at-risk adolescents will be recruited from participants in an NIMH-funded extramural study at New York University (NYU) examining the biology of risk for anxiety and depressive disorders. Over a three-year period, 30 high-risk probands and 45 low-risk comparisons will be studied, including 20 comparisons from the NYU sample and 25 from the Washington DC metropolitan area. In the present protocol, to be conducted at NIH, subjects will undergo volumetric MRI scans to assess structural abnormalities in the prefrontal cortex and medial temporal lobe. They will complete a series of four out-of-scanner cognitive tasks and two fMRI-based cognitive tasks that measure modulation of attention to emotional stimuli. The fMRI tasks are hypothesized to differentially engage the prefrontal cortex and amygdala in low vs. high risk subjects. These tasks will be used to test the hypothesis that at-risk individuals exhibit enhanced amygdala and reduced prefrontal activation on the fMRI emotion/attention tasks.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Age 10-17. Can give consent/assent. Parents will provide consent for all minors. All subjects will have IQ greater than 80. High risk: Offspring of adults with MDD who have a history of childhood anxiety symptoms. Low risk: No history of parental MDD or childhood anxiety. A prior history of childhood anxiety symptoms will be an inclusion criterion, but children exhibiting current clinically significant anxiety disorders beyond specific phobias will be excluded. EXCLUSION CRITERIA: Any medical condition that increases risk for MRI (e.g. pacemaker, metallic foreign body in eye). Pregnancy. All subjects will be free of current impairing affective disorders, separation anxiety disorder, social anxiety disorder, panic disorder, generalized anxiety disorder, PTSD, ADHD, as well as lifetime history of substance dependence, psychosis, pervasive developmental disorder, major affective disorder, obsessive compulsive disorder, conduct disorder, anorexia.
Total Enrollment: 95
Location and Contact Information:
National Institute of Mental Health (NIMH) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 030014; 03-M-0014
Study Start Date: October 12, 2002
Record last reviewed: September 12, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00047944
Other Anxiety Disorders Studies:
1. Heart Disease Risk Factors in Major Depression
2. Dynamics of Leptin and Endocrine Function
3. Bone Mineral Density in Women with Major Depression
4. MRI Study of Brain Activity and Risk for Depression in Adolescents
5. Study of the Psychological Development of Children of Parents with and without Affective Disorders
Related Studies:
Other Anxiety Disorders Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
MRI Study of Brain Activity and Risk for Depression in Adolescents
|
|
|
|
|
|
|
|
